Literature DB >> 27464797

Chemical Screening in Zebrafish.

Colleen A Brady1,2,3, Andrew J Rennekamp1,2,3, Randall T Peterson4,5,6.   

Abstract

Phenotypic small molecule screens in zebrafish have gained popularity as an unbiased approach to probe biological processes. In this chapter we outline basic methods for performing chemical screens with larval zebrafish including breeding large numbers of embryos, plating larval fish into multi-well dishes, and adding small molecules to these wells. We also highlight important considerations when designing and interpreting the results of a phenotypic screen and possible follow-up approaches, including popular methods used to identify the mechanism of action of a chemical compound.

Entities:  

Keywords:  Multi-well plates; Phenotypic screening; Small molecules

Mesh:

Substances:

Year:  2016        PMID: 27464797     DOI: 10.1007/978-1-4939-3771-4_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Opportunities and challenges for using the zebrafish to study neuronal connectivity as an endpoint of developmental neurotoxicity.

Authors:  Galen W Miller; Vidya Chandrasekaran; Bianca Yaghoobi; Pamela J Lein
Journal:  Neurotoxicology       Date:  2018-04-25       Impact factor: 4.294

2.  Time-dependent behavioral data from zebrafish reveals novel signatures of chemical toxicity using point of departure analysis.

Authors:  Dennis G Thomas; Harish Shankaran; Lisa Truong; Robert L Tanguay; Katrina M Waters
Journal:  Comput Toxicol       Date:  2018-11-10

3.  Zebrafish phenotypic screen identifies novel Notch antagonists.

Authors:  Vithya Velaithan; Kazuhide Shaun Okuda; Mei Fong Ng; Norazwana Samat; Sze Wei Leong; Siti Munirah Mohd Faudzi; Faridah Abas; Khozirah Shaari; Sok Ching Cheong; Pei Jean Tan; Vyomesh Patel
Journal:  Invest New Drugs       Date:  2017-01-05       Impact factor: 3.850

4.  Transcriptomic profiling of mTOR and ryanodine receptor signaling molecules in developing zebrafish in the absence and presence of PCB 95.

Authors:  Daniel F Frank; Galen W Miller; Richard E Connon; Juergen Geist; Pamela J Lein
Journal:  PeerJ       Date:  2017-11-29       Impact factor: 2.984

Review 5.  Zebrafish in Translational Cancer Research: Insight into Leukemia, Melanoma, Glioma and Endocrine Tumor Biology.

Authors:  Aurora Irene Idilli; Francesca Precazzini; Maria Caterina Mione; Viviana Anelli
Journal:  Genes (Basel)       Date:  2017-09-20       Impact factor: 4.096

6.  Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.

Authors:  Karine Audouze; Denis Sarigiannis; Paloma Alonso-Magdalena; Celine Brochot; Maribel Casas; Martine Vrijheid; Patrick J Babin; Spyros Karakitsios; Xavier Coumoul; Robert Barouki
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

7.  A Multiparametric Assay Platform for Simultaneous In Vivo Assessment of Pronephric Morphology, Renal Function and Heart Rate in Larval Zebrafish.

Authors:  Petrus J Steenbergen; Jana Heigwer; Gunjan Pandey; Burkhard Tönshoff; Jochen Gehrig; Jens H Westhoff
Journal:  Cells       Date:  2020-05-20       Impact factor: 6.600

8.  Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant.

Authors:  Elvira Diamantopoulou; Sarah Baxendale; Antonio de la Vega de León; Anzar Asad; Celia J Holdsworth; Leila Abbas; Valerie J Gillet; Giselle R Wiggin; Tanya T Whitfield
Journal:  Elife       Date:  2019-06-10       Impact factor: 8.713

Review 9.  Advancing human disease research with fish evolutionary mutant models.

Authors:  Emily A Beck; Hope M Healey; Clayton M Small; Mark C Currey; Thomas Desvignes; William A Cresko; John H Postlethwait
Journal:  Trends Genet       Date:  2021-07-29       Impact factor: 11.639

Review 10.  Zebrafish as a Model for Drug Screening in Genetic Kidney Diseases.

Authors:  Jochen Gehrig; Gunjan Pandey; Jens H Westhoff
Journal:  Front Pediatr       Date:  2018-06-28       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.